Foley Advises EpiVax in Acquisition by SV Health Investors

Foley & Lardner LLP served as legal advisor to EpiVax Inc., a leading bioanalytical contract research organization specializing in immunogenicity risk assessments for pharmaceutical and biotech companies, in its acquisition by SV Health Investors, a health care and life sciences focused private investment firm. EpiVax is a pioneer in pre-clinical drug development, serving as a […]